OncoScreen (ST2.0, Extended RAS-Assay)

The OncoScreen ST2.0 assay is designed to sequence hot-spot mutational regions of 50 clinically relevant genes that are commonly mutated in cancer for the purpose of identifying somatic mutations (substitutions and insertions/deletions). Mutations in these 50 genes are linked to many types of cancers, including lung, colorectal, gastric, thyroid, ovarian cancer, melanoma and myeloid malignancies.Mutations with known clinical significance and/or those deemed to be pathogenically related to the biology of each patient’s tumor are reported, and this personalized mutational profile may be useful fordiagnosis, prognosis, therapy selection, clinical trials options and for translational research.

For more details and ordering, please click here.